Onderneming Galena Biopharma Inc Nasdaq
Aandelen
US3632561086
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 03-04-06 |
John Burns
DFI | Director of Finance/CFO | 39 | 01-05-13 |
Andrew Elnatan
LAW | General Counsel | - | 05-01-23 |
Dragan Cicic
PRN | Corporate Officer/Principal | 60 | 10-02-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 29-12-17 | |
David Scheinberg
BRD | Director/Board Member | 68 | 01-12-17 |
John Varian
BRD | Director/Board Member | 64 | 29-12-17 |
Jane Wasman
CHM | Chairman | 67 | 29-12-17 |
Angelos Stergiou
FOU | Founder | 48 | 03-04-06 |
Katherine Kalin
BRD | Director/Board Member | 61 | 13-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 754 928 | 57 598 688 ( 99,73 %) | 0 | 99,73 % |
Bedrijfsgegevens
SELLAS Life Sciences Group, Inc.
Times Square Tower 7 Times Square
10026, New York
+
http://www.sellaslifesciences.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+6,79% | 14,16 mld. | |
+38,61% | 12,63 mld. |